Written by Klarity Editorial Team
Published: Apr 10, 2026

If you’ve been lying awake at 3 AM scrolling through your phone, wondering if there’s a faster way to get help for your insomnia, you’re not alone. Millions of Americans struggle with sleep disorders, and many are turning to telehealth for convenient, accessible care. But can you actually get prescription sleep medication through a virtual visit?
The short answer: Yes, in most cases. Telehealth providers can legally prescribe certain insomnia medications nationwide, often without requiring an in-person visit. However, the type of medication, your state’s laws, and your individual situation all play a role in what’s available through virtual care.
In this guide, we’ll break down exactly how telehealth insomnia treatment works in 2025, which medications can be prescribed online, state-specific rules you need to know, and when virtual care is (and isn’t) the right choice for your sleep problems.
At the federal level, prescribing rules depend on whether a medication is classified as a ‘controlled substance’ by the Drug Enforcement Administration (DEA).
For non-controlled insomnia medications (like trazodone or low-dose doxepin), there are no federal barriers to telehealth prescribing. The Ryan Haight Act of 2008—which requires an in-person exam before prescribing controlled substances online—does not apply to medications that aren’t classified as controlled. This means healthcare providers across the country can evaluate your insomnia via video or phone and prescribe these medications legally, as long as they meet standard-of-care requirements.
For controlled sleep medications (such as zolpidem/Ambien, eszopiclone/Lunesta, or benzodiazepines), the situation is more complex. Normally, the Ryan Haight Act would require an initial in-person medical evaluation. However, during the COVID-19 pandemic, the DEA temporarily waived this requirement to expand access to care.
As of December 2025, this temporary flexibility remains in effect through the end of the year, marking the third extension of these emergency rules. The DEA and Department of Health and Human Services extended the waiver through December 31, 2025, while they continue working on permanent regulations. This means providers can currently prescribe Schedule II–V controlled substances via telehealth without an initial in-person visit—though this flexibility may change in 2026 when new federal rules are expected.
Because of the regulatory uncertainty around controlled substances, many reputable telehealth platforms focus on non-controlled insomnia treatments. These medications are:
The two most commonly prescribed non-controlled sleep medications are trazodone (an antidepressant used off-label for insomnia) and low-dose doxepin (marketed as Silenor when prescribed specifically for sleep). Both have been studied for insomnia treatment and can be prescribed with refills, making them practical options for ongoing telehealth management.
While federal law sets the baseline, each state has its own telehealth regulations that can add requirements or restrictions. Here’s what the rules look like in major states as of December 2025:
California, Texas, Florida, and New York all permit telehealth prescribing of non-controlled insomnia medications without requiring any in-person visit. In these states:
California is considering legislation (AB 1503) that would further expand telehealth by allowing asynchronous evaluations (online questionnaires) in some cases, though this isn’t law yet. Texas requires that telemedicine visits for prescribing use two-way audio-video when treating certain conditions like chronic pain, but this primarily affects controlled substances; for straightforward insomnia treatment with non-controlled meds, phone consultations may suffice.
Florida has a notable restriction: the state bans telehealth prescribing of Schedule II controlled substances (with limited exceptions for psychiatric, inpatient, or hospice patients). However, this doesn’t affect non-controlled insomnia medications like trazodone or doxepin, which remain fully accessible via telehealth.
New Hampshire made significant changes in 2025. Effective August 23, 2025, the state eliminated its prior in-person exam requirement for telehealth prescribing through Senate Bill 252. Now, New Hampshire providers can prescribe medications—including controlled substances—via telehealth as long as they conduct an appropriate evaluation and schedule at least annual follow-ups. This progressive approach reflects growing confidence in telemedicine quality.
Delaware also updated its rules in 2025 with Senate Bill 101, which clarified that telehealth can be used to prescribe buprenorphine for opioid use disorder without an in-person visit. While this primarily affects addiction treatment, it signals Delaware’s support for telehealth prescribing generally. Non-controlled insomnia medications have always been available via telehealth in Delaware.
Alabama is more restrictive than most states. Under rules adopted in 2022, if a patient has more than four telehealth visits for the same medical issue within one year without any in-person examination, the provider must refer the patient for an in-person evaluation within 12 months. This rule applies to all telehealth care, not just insomnia treatment.
What this means: If you’re an Alabama resident using telehealth for chronic insomnia management, you’d likely need to see a local provider for at least one in-person visit per year to stay compliant with state regulations. This doesn’t prevent initial telehealth prescribing, but it does require occasional in-person follow-up for long-term care.
Regardless of state prescribing rules, providers must be licensed in your state to treat you. Most COVID-era waivers allowing out-of-state providers to practice temporarily have expired. Reputable telehealth platforms like Klarity Health address this by:
Always confirm that your telehealth provider is properly licensed where you live. This is a fundamental legal requirement separate from the question of what medications can be prescribed.
MDs and DOs (physicians) can prescribe any FDA-approved medication—controlled or non-controlled—within their scope of practice in any state, including via telehealth. If your telehealth provider is a physician, they have full prescribing authority for insomnia medications, subject only to the federal and state rules discussed above.
Nurse Practitioners (NPs) and Physician Assistants (PAs) are advanced practice providers who can also prescribe medications, but their level of independence varies by state:
Independent Practice States: In approximately 27 states (including New Hampshire, New York after experience requirements, and several others), NPs have full practice authority. This means they can evaluate patients, diagnose conditions, and prescribe medications—including sleep aids—without physician oversight. In these states, you might see an NP independently via telehealth who manages your entire insomnia treatment.
Collaborative Practice States: Many large states like California, Texas, Florida, and Georgia are ‘reduced practice’ or ‘restricted practice’ states where NPs require a collaborative agreement with a physician. In Texas, for example, NPs can prescribe non-controlled medications in any setting under a Prescriptive Authority Agreement with a supervising physician. Florida requires protocol agreements, though some experienced Florida NPs have gained more autonomous practice authority in primary care since 2020 law changes.
The key point: In every state, NPs and PAs can prescribe non-controlled insomnia medications (like trazodone or doxepin) either independently or under appropriate physician collaboration. The supervision requirements don’t prevent access to care—they simply mean a physician partner may be part of the oversight structure, even if you don’t interact with them directly.
Important limitations: Some states restrict NPs and PAs from prescribing Schedule II controlled substances even with physician agreements. For instance, Texas NPs cannot prescribe Schedule II drugs outside hospital or hospice settings, and Alabama and Georgia prohibit NP/PA prescribing of Schedule IIs entirely. However, these restrictions don’t apply to the non-controlled sleep medications commonly used in telehealth insomnia treatment.
Healthcare access advocates note that NP scope of practice is gradually expanding. Since 2020, states like California (through AB 890) have implemented pathways for NPs to gain full practice authority after supervised experience hours. Illinois, Massachusetts, and Delaware have also enhanced NP independence. This trend improves telehealth access, as platforms can employ NPs who practice fully independently in many states, reducing bottlenecks in scheduling and care delivery.
At Klarity Health, our network includes both physicians and advanced practice providers licensed across the states we serve. We match you with qualified clinicians who can legally and safely prescribe appropriate insomnia treatments in your location—whether that’s an independent NP in a full-practice state or a collaborative team in states requiring physician oversight. What matters most is that you receive evidence-based, personalized care from properly credentialed professionals.
Trazodone is an antidepressant medication that’s frequently prescribed off-label for insomnia. At low doses (typically 25–100 mg at bedtime), it helps people fall asleep and stay asleep by affecting serotonin receptors. Because trazodone is not a controlled substance, it can be prescribed via telehealth in all 50 states with no special federal restrictions.
Benefits of trazodone for telehealth patients:
Common approach: Telehealth providers often start with a 30-day supply to assess how you respond, then authorize refills for ongoing management with periodic virtual check-ins.
Doxepin (low-dose) is another antidepressant that, at very low doses (3–6 mg), is FDA-approved specifically for insomnia under the brand name Silenor. Like trazodone, low-dose doxepin is not controlled, making it fully accessible via telehealth.
Benefits of low-dose doxepin:
Both medications require legitimate prescriptions and cannot be purchased over-the-counter or from unregulated online pharmacies. Your telehealth provider will send an electronic prescription to your chosen pharmacy, where you can pick it up or arrange delivery just like any other medication.
Benzodiazepines (such as temazepam/Restoril, triazolam/Halcion) and ‘Z-drugs’ (zolpidem/Ambien, eszopiclone/Lunesta, zaleplon/Sonata) are Schedule IV controlled substances. While the temporary DEA waiver technically allows their prescription via telehealth through December 2025, many telehealth platforms choose not to prescribe them due to:
Some specialized sleep medicine telehealth services may offer these medications in carefully selected cases, but you’re less likely to receive them from general telehealth mental health platforms.
If you’ve been on a controlled sleep medication long-term and need refills, telehealth providers may continue existing prescriptions (especially if you have recent in-person documentation), but most won’t initiate these medications for new patients purely through virtual visits.
Telehealth providers can also recommend or discuss OTC sleep aids like:
However, for chronic insomnia, OTC options are typically less effective than prescription treatments or behavioral interventions. A thorough telehealth evaluation will help determine whether OTC products, prescription medication, therapy, or a combination is best for your situation.
Telehealth insomnia treatment works well for:
Primary insomnia: Difficulty sleeping that’s not caused by another medical condition, medication side effect, or substance use. This includes chronic insomnia (lasting more than 3 months with sleep problems at least 3 nights per week) and adjustment insomnia (short-term sleep problems related to stress or life changes).
Mild to moderate cases: People who are functional during the day but experiencing daytime fatigue, concentration problems, irritability, or other quality-of-life impacts from poor sleep.
Patients seeking medication combined with lifestyle changes: Those willing to work on sleep hygiene, limit caffeine/alcohol, and possibly engage in cognitive behavioral therapy for insomnia (CBT-I)—which many telehealth platforms offer or can refer you to.
People with scheduling or transportation barriers: Individuals who find it difficult to take time off work for in-person appointments, live in rural areas with limited specialist access, or have mobility challenges that make office visits burdensome.
Those with coexisting anxiety or depression: Since insomnia often occurs alongside mental health conditions, telehealth platforms that treat both (like Klarity Health) can address multiple concerns in an integrated way.
Telehealth providers will refer you for in-person evaluation if they suspect:
Obstructive sleep apnea (OSA): If you snore loudly, gasp or choke during sleep, have witnessed breathing pauses, or wake up with headaches and extreme fatigue, you may need a sleep study. OSA requires diagnosis through polysomnography (overnight monitoring in a sleep lab or home sleep test), which can’t be done virtually. Treating OSA with CPAP therapy (not medication) is the appropriate intervention.
Other sleep disorders: Conditions like restless legs syndrome, periodic limb movement disorder, narcolepsy, or parasomnias (sleepwalking, night terrors) may require specialized testing or in-person neurological examination.
Serious underlying medical conditions: If insomnia might be caused by uncontrolled thyroid disease, chronic pain, heart problems, or neurological disorders, you need comprehensive medical workup that telehealth cannot provide. Lab tests, imaging, or physical examinations may be necessary.
Psychiatric emergencies: Severe depression with suicidal thoughts, active psychosis, or untreated bipolar disorder are not appropriate for routine telehealth insomnia visits. These situations require urgent in-person mental health care or emergency services.
Red-flag symptoms: Seek immediate in-person or emergency care if you experience:
Reputable telehealth services screen for these conditions during intake and evaluation. If your provider identifies any concerning features, they’ll direct you to appropriate in-person resources rather than simply prescribing medication.
Clinical guidelines from the American Academy of Sleep Medicine identify CBT-I as the first-line treatment for chronic insomnia. This structured therapy helps you identify and change thoughts and behaviors that interfere with sleep. Components include:
Many telehealth platforms now offer CBT-I through:
Medication and CBT-I often work together. Your telehealth provider might prescribe trazodone for short-term relief while you work through a CBT-I program, with the goal of eventually relying primarily on behavioral strategies. This integrated approach addresses both immediate symptoms and long-term sleep patterns.
At Klarity Health, we take a comprehensive approach to insomnia—not just prescribing pills. Our providers assess your overall sleep health, discuss lifestyle factors, and can connect you with appropriate therapy resources when indicated. The goal is sustainable sleep improvement, not just short-term sedation.
Your first telehealth appointment will typically last 30–45 minutes and include:
Sleep history: Your provider will ask detailed questions about:
Medical and psychiatric history:
Lifestyle factors:
Screening for other disorders: Your provider will assess whether symptoms suggest sleep apnea, restless legs, or other conditions requiring different treatment. They may use standardized screening questionnaires (like the STOP-BANG for sleep apnea risk or Epworth Sleepiness Scale for daytime drowsiness).
If your provider determines medication is appropriate, they’ll discuss:
They’ll send an electronic prescription to your pharmacy of choice. In states requiring e-prescribing (like California and New York), this is mandatory; in others, it’s standard practice for efficiency and accuracy.
Your provider will also likely recommend non-pharmacological strategies as part of your treatment plan, such as:
Ongoing management is essential for insomnia treatment. Typical follow-up includes:
Initial check-in (2–4 weeks): After starting medication, you’ll have a brief follow-up (often 15–20 minutes) to assess:
Ongoing monitoring (every 1–3 months): For chronic insomnia requiring longer-term medication, most providers schedule quarterly virtual check-ins. These visits ensure:
State-specific requirements: Some states mandate periodic follow-ups. For example, New Hampshire law (effective 2025) requires at least annual appropriate follow-up for any ongoing telemedicine prescribing relationship. Alabama requires in-person evaluation if you exceed four telehealth visits for the same condition in a year without any in-person exam.
Refills: For non-controlled medications like trazodone or doxepin, providers can authorize refills for up to 12 months (common practice is 90-day supplies with several refills). Many platforms have patient portals where you can request refills between appointments if needed, which the provider can approve after reviewing your records.
Not all online prescribing services are legitimate or safe. Avoid any platform that:
Prescribes without a live consultation: Websites offering sleep medications based solely on an online questionnaire (with no video or phone consultation with a licensed provider) may be operating illegally or unethically. While some states are exploring asynchronous care, current standards require a real-time or interactive evaluation to establish the provider-patient relationship.
Doesn’t verify your location or provider license: Legitimate services confirm both your state of residence and that your assigned provider is licensed in your state. If a site doesn’t ask where you live or makes vague claims about ‘licensed nationwide,’ that’s a warning sign.
Promises controlled substances with minimal screening: If an online service heavily advertises Ambien, Xanax, or other controlled meds and seems to prescribe them to anyone who requests them, this is likely a pill mill operation. Ethical providers use careful screening and prefer non-controlled options when appropriate.
Lacks transparency about costs: Reputable platforms clearly list consultation fees, whether they accept insurance, and typical medication costs. Hidden fees or unclear pricing is a red flag.
Has poor provider credentials or vague information: You should be able to see your provider’s full name, credentials (MD, DO, NP, PA), license number, and state(s) of licensure. If the platform doesn’t disclose who will treat you, be cautious.
Discourages follow-up or monitoring: Quality care includes follow-up. If a service gives you a prescription and then ghosts you with no mechanism for follow-up visits or questions, that’s inappropriate medical practice.
Quality virtual insomnia care includes:
At Klarity Health, we prioritize safe, personalized care for sleep disorders:
Licensed providers in your state: All our clinicians are fully licensed where you live, whether that’s a psychiatrist, psychiatric nurse practitioner, or physician assistant—ensuring legal compliance and local expertise.
Comprehensive evaluations: We don’t just hand out prescriptions. Our providers spend time understanding your sleep patterns, overall health, and what treatments have or haven’t worked for you in the past.
Evidence-based medication choices: We focus on non-controlled medications like trazodone and low-dose doxepin, which are effective, have lower abuse potential, and are unaffected by changing DEA rules—giving you continuity of care.
Integrated mental health care: Since insomnia often coexists with anxiety, depression, or ADHD, our providers can address multiple concerns in one place. If you’re already a Klarity patient for another condition, we can incorporate sleep management into your existing treatment plan.
Flexible access and transparent pricing: We offer both insurance-based and cash-pay options, with clear pricing (typically around $79–$199 for initial consultations depending on your state and insurance). Appointments are available evenings and weekends, fitting your schedule.
Ongoing support: After your initial visit, we make follow-up easy through our patient portal. You can message your provider, request refills, or schedule check-ins without navigating complex phone trees.
Provider availability: Unlike some platforms with long wait times, Klarity typically offers appointments within days, not weeks. We know when you’re struggling with sleep, waiting a month for help isn’t realistic.
We’re committed to expanding access to mental health and sleep care while maintaining the highest clinical standards. If during your evaluation we determine that in-person care is needed (for example, if you show signs of sleep apnea), we’ll help you find local resources—we never push a telehealth solution when it’s not clinically appropriate.
Can I get Ambien or other ‘Z-drugs’ through telehealth?
Maybe, but it depends on the platform and your situation. The temporary federal waiver (extended through December 2025) allows telehealth prescribing of controlled substances like zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon (Sonata). However, many telehealth platforms avoid prescribing these medications due to:
Some specialized sleep medicine telehealth services may prescribe controlled sleep aids in specific circumstances, typically for patients who’ve tried other options without success and have recent in-person medical documentation. If you’re currently taking a controlled sleep medication and need refills, telehealth providers are more likely to continue existing therapy than to initiate it for new patients.
Do I need to see a doctor in person before getting sleep medication online?
For non-controlled medications (like trazodone or low-dose doxepin), no in-person visit is required under federal law or in most states. Your telehealth consultation—conducted via video, phone, or other interactive technology—is legally sufficient to establish the provider-patient relationship needed for prescribing.
For controlled substances, the temporary DEA waiver (through December 2025) currently allows prescribing without a prior in-person exam. However, some individual states have added their own requirements:
Future federal rules (expected in 2026) may reinstate in-person exam requirements for controlled substances nationwide, but non-controlled insomnia medications will remain accessible via telehealth only.
How much does telehealth insomnia treatment cost?
Costs vary by platform and insurance:
With insurance: Many insurance plans now cover telehealth at the same rate as in-person visits, thanks to telehealth parity laws. Your copay might be $10–$50 depending on your plan, or the visit may count toward your deductible.
Self-pay: Initial consultations typically range from $79–$250. At Klarity Health, initial visits are typically $79–$199 depending on your state, with follow-ups around $59–$149. Some platforms use subscription models (monthly fees) while others charge per visit.
Medications: Prescription costs are separate and depend on your pharmacy and insurance. Generic trazodone is very affordable (often $5–$20/month), while brand-name Silenor (low-dose doxepin) may cost more without insurance. Your provider can discuss cost-effective options.
Total cost comparison: Telehealth is often more affordable than in-person specialist visits when you factor in:
At Klarity Health, we accept most major insurance plans and also offer transparent cash-pay pricing, so you know costs upfront without surprise billing.
What states have the best telehealth access for sleep treatment?
States with minimal restrictions and full NP independence offer the broadest telehealth access:
States where access is good but with some limitations:
States requiring more coordination with in-person care:
Regardless of state, platforms like Klarity Health that operate in multiple states can connect you with appropriately licensed providers. The state-level differences primarily affect which provider type you’ll see (independent NP vs. physician-supervised) and whether any periodic in-person visits are eventually needed.
Can I use telehealth if I’ve tried sleep medications before?
Yes. Telehealth providers want to know your full treatment history, including:
This information helps your provider make informed recommendations. If you’ve had poor results with multiple medications, they might suggest a different class of medication, dose adjustment, combination with therapy, or referral to a sleep specialist for more complex evaluation.
Telehealth is particularly useful for medication adjustments and ongoing management if you’ve been on sleep medication before and know what works (or doesn’t work) for you. However, if you’ve tried many medications without success, in-person sleep medicine evaluation with possible sleep study might be more appropriate.
Is telehealth prescribing safe and legal?
When done properly, yes. Telehealth prescribing is:
Legal: All 50 states permit telemedicine in some form, and there are no federal laws preventing the prescription of non-controlled medications via telehealth. Providers must be licensed in your state and follow standard prescribing regulations. The temporary DEA waiver also currently allows controlled substance prescribing via telehealth through December 2025.
Safe: Studies show telehealth outcomes for many conditions, including mental health and insomnia management, are comparable to in-person care when appropriate patient selection and clinical protocols are followed. The key is using a legitimate service with credentialed providers who conduct thorough evaluations—not ‘pill mill’ websites that prescribe without proper assessment.
Regulated: State medical boards oversee telehealth practice just as they do in-person care. Providers can face discipline for substandard telehealth care, inappropriate prescribing, or failing to meet documentation requirements. Reputable platforms maintain high standards to protect both patients and providers.
What to verify:
Using a telehealth platform that’s transparent about provider credentials, pricing, and clinical approach—like Klarity Health—ensures you receive legitimate, safe medical care from the comfort of home.
The DEA is expected to finalize permanent telemedicine rules in 2026, potentially requiring:
These changes would primarily affect controlled sleep medications like zolpidem (Ambien), while non-controlled options remain unaffected. Telehealth platforms are preparing for these changes by:
Congressional action is also possible. Bills like the TREATS Act aim to modify the Ryan Haight Act to permanently expand telehealth access for mental health and addiction treatment. Healthcare organizations, patient advocates, and telehealth companies are lobbying to preserve at least some of the flexibility gained during the pandemic.
Telehealth for sleep disorders is evolving beyond just prescribing:
Digital therapeutics: FDA-cleared apps for CBT-I (like Somryst) provide structured, self-guided therapy that’s proven effective. These may be prescribed alongside or instead of medication, with telehealth providers monitoring your progress.
Home sleep testing: While full polysomnography still requires a lab, home sleep apnea tests are becoming more accessible. Some telehealth platforms can order home tests for appropriate patients, expanding diagnostic capabilities.
Wearable integration: Sleep tracking via devices like Oura Ring, Apple Watch, or Fitbit provides objective data that patients can share with telehealth providers. While not diagnostic-grade, this data helps guide treatment adjustments.
Hybrid care models: The future likely involves seamless integration of telehealth and in-person care. For example, you might have quarterly in-person visits with a local provider and more
Find the right provider for your needs — select your state to find expert care near you.